Drugmakers will be required to pay Medicare back for price increases that outpace inflation. The industry is expected to put up a fight over implementation.
Insurers, employers, taxpayers and other consumers will all be affected as drugmakers move these products to the commercial market in May. How much you'll pay depends on your health insurance.
Policymakers have long grappled with how to handle experiments that might generate potentially dangerous viruses. Now, officials are considering whether oversight needs to be expanded.
Long criticized as discriminatory, the policy has prevented many gay and bisexual men from donating blood. The Food and Drug Administration revealed a draft of its new approach on Friday.
Advisers to the U.S. Food and Drug Administration today endorsed a proposal to make big changes in the nation's approach to vaccinating people against COVID-19.
Toxic metal can be harmful to developing brains. New lead targets are part of a broad FDA imitative to reduce children's exposure to the lowest levels possible.
Since early in the pandemic, people on Medicaid have been able to stay enrolled without reapplying. That will change in April and millions of eligible people will lose the coverage.
Climate goals can feel distant. But climate change is happening right now. Speed up the benefits for taking action, psychologists say, if you want leaders and others to pay attention and act.
An investigation finds that corrections officers in Pennsylvania use physical force on people who may be unable to comply with orders due to a mental health condition.
The ruling is the latest twist in a long-running dispute over where dozens of federally-supported former research chimps should live out the remainder of their days.
The advent of vaping revived nicotine addiction among young people after a dramatic decline. The FDA seems poised to at last yank some products aimed at teens from the market. Will it work?
